SPONSOR
Universita di Verona
Total Trials
2
Recruiting
2
Phases
Phase 4
Conditions studied: Rheumatoid ArthritisHeart Failure with Preserved Ejection Fraction (HFPEF)Heart Failure with Reduced Ejection FractionSarcopenia in ElderlySarcopenic Obesity
Universita di Verona is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Rheumatoid Arthritis, Heart Failure with Preserved Ejection Fraction (HFPEF), Heart Failure with Reduced Ejection Fraction, Sarcopenia in Elderly.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Universita di Verona
How many clinical trials has Universita di Verona sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Universita di Verona, of which 2 are actively recruiting participants. These trials cover conditions including Rheumatoid Arthritis, Heart Failure with Preserved Ejection Fraction (HFPEF), Heart Failure with Reduced Ejection Fraction. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Universita di Verona research focus on?
Universita di Verona clinical trials span Rheumatoid Arthritis, Heart Failure with Preserved Ejection Fraction (HFPEF), Heart Failure with Reduced Ejection Fraction, Sarcopenia in Elderly, Sarcopenic Obesity. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Universita di Verona clinical trial?
To participate in a Universita di Verona trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Universita di Verona trials with current recruitment status updated daily.
Clinical Trials by Universita di Verona
NCT06527534 Phase 4
Recruiting
Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA)
Rheumatoid Arthritis
NCT06826963
Recruiting
Feasibility and Effectiveness of Eccentric Exercise in Sarcopenic Older Adults with Heart Failure: a Pilot Study
Heart Failure with Preserved Ejection Fraction (HFPEF)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology